Micro Cap Finds Mid-Week Success Following Patent Announcement

A New York-based healthcare company is finding a tremendous amount of success on Wednesday after it was announced that the company has been granted and issued a patent in Europe, EP3377091B1, for the use of its Klotho gene sequence and gene delivery systems for the treatment of diminished cognition, memory loss, dementia and other neurodegenerative diseases, according to a press release. 

Traders were quick to snitch up shares of Anew Medical Inc. (Nasdaq:WENA), pushing shares up to $5.11/share (+209.70%) at the early session high. 

Anew Medical Inc. is a global medical products company focused on development, manufacturing and distribution of patented therapies for advanced wound care, scar management, and skin care. We understand both the physical and psychological impact of wounds and the scars they create and are dedicated to supplying medical professionals with new solutions and on improving quality of life for patients.

Copyright © 2024 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com’s content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

View the original article on AllPennyStocks.com

]]>